FDA
approval
· 2022-02-09
FDA Approved: XYWAV — Supplemental Application (Jazz Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for XYWAV, the calcium, magnesium, potassium, and sodium oxybates product from Jazz Pharmaceuticals. The approval pertai…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)